VASC Related Analyst Ratings
-
Piper Jaffray Starts Vascular Solutions (VASC) at Overweight
-
Benchmark Downgrades Vascular Solutions (VASC) to Hold on Valuation
-
Sidoti Downgrades Vascular Solutions (VASC) to Neutral
-
Analysts Expect More Margin Expansion and Top Line Growth at Vascular (VASC)
-
Sidoti Upgrades Vascular Solutions (VASC) to Buy
-
Sidoti Downgrades Vascular Solutions (VASC) to Neutral
-
Canaccord Genuity Reiterates a 'Buy' on Vascular Solutions (VASC); Another Beat and Raise
-
Dougherty & Co Maintains a 'Buy' on Vascular Solutions (VASC); Q2 Preview
-
Canaccord Genuity Reiterates a 'Buy' on Vascular Solutions (VASC); Expect Strong Q2 - Add to Positions
-
Benchmark Starts Vascular Solutions (VASC) at Buy; Catheter Products are Key
-
Dougherty & Co Upgrades Vascular Solutions (VASC) to Buy; Strong Q1 and Improved Outlook
-
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Raising PT After Strong Results
-
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Q4 Mixed; 2012 Looks Like Transition Year
-
Highlights From Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference Part III
-
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Mixed Q3 and Underwhelming Guidance
-
Duncan Williams Raises Price Target on Vascular Solutions (VASC), Strong Quarter
-
Canaccord Genuity Reiterates a 'Buy' on Vascular Solutions (VASC); Margin Leverage Continues; Attractive GARP Idea
-
Canaccord Genuity Reiterates a 'Buy' on Vascular Solutions (VASC); Margin Leverage Near a Tipping Point
-
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Reports Q2 In-Line
-
Stifel Nicolaus Initiates Coverage on Medical Equipment/Technology Stocks VASC & CFN
-
Canaccord Adams Reiterates a 'Buy' Rating on Vascular Solutions (VASC); Solid Q1 Results
-
Wedbush Initiates Coverage on Vascular Solutions (VASC) with an Outperform
-
Duncan-Williams Places 'Buy' Rating on Vascular Solutions (VASC); "Aging of the Population" to Drive Increase in Demand/Volume
-
Duncan Williams Initiates Coverage on Vascular Solutions (VASC) with a Buy
-
Canaccord Adams Assumes Coverage on Vascular Solutions (VASC) with a Buy
-
Canaccord Adams Maintains a 'Buy' on Vascular Solutions (VASC); Raises Price Target & Estimates
-
RBC Capital Starts Vascular Solutions (VASC) at Outperform
-
SunTrust Starts Vascular Solutions (VASC) at Buy
-
FTN Midewest upgrades Vascular Solutions Inc. (VASC) to Buy
-
Janney Montgomery Upgrades Vascular Solutions (VASC) to Buy
-
FTN Midwest Upgraded Vascular Solutions (VASC) To Neutral
-
Adams Harkness Starts VASC at Buy
Back to VASC Stock Lookup
